We made use of all the previously published data (535 tumours) and unpublished data from the Henri Mondor, Foch, IGR, and Saint-Louis hospitals (382 tumours) for analyses of both FGFR3 and TP53 mutations, in a meta-analysis investigating the relationship between these two mutations. This evidence concerns the gene FGFR3 and neoplasm.